跳至主要内容
临床试验/JPRN-UMIN000027941
JPRN-UMIN000027941招募中未知

Exploratory research on efficacy and safety of transarterial chemo-embolization with warmed miriplatin for unresectable hepatocellular carcinoma - efficacy and safety of TACE with warmed miriplatin for unresectable HCC

The University of Tokyo0 个研究点目标入组 30 人开始时间: 2017年6月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) severly impaired liver function (Child-Pugh C) 2) jaundice with T-bil >=3mg/dL 3) severely impaired renal function (eGFR < 30 mL/min/1.73m2) 4) past history with allergy or severe adverse events after TACE 5) marked history of hypersensitivity to miriplatin, other platinum-containing drugs or iodine-containing drugs 6) uncontrolled severe thyroid disorder 7) pregnant, lactating 8) dementia with difficuty conducting TACE 9) patients judged inadequate by investigators

研究者

相似试验